UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032074
Receipt number R000035973
Scientific Title A case-control study on the influence of glycolipid GM3 in glomerular disease
Date of disclosure of the study information 2018/04/10
Last modified on 2021/10/13 17:09:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A case-control study on the influence of glycolipid GM3 in glomerular disease

Acronym

GM3 in glomerular disease study

Scientific Title

A case-control study on the influence of glycolipid GM3 in glomerular disease

Scientific Title:Acronym

GM3 in glomerular disease study

Region

Japan


Condition

Condition

glomerular disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluate the association between glycolipid GM3 expression and glomerular disease.

Basic objectives2

Bio-availability

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

proteinuria, renal function after 2 years of renal biopsy

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1) Diseased:
Patients diagnosed with renal biopsyin in Kitasato university hospital, division of nephrology(2010/1/1-2015/12/31)
a) MCNS, b) FSGS, c) IgA-nephritis, d) Membrane nephritis, e) DM-N

2) control
Nephrectomy patients who assent in Kitasato University Hospital, Division of Urology (2018/4/1-2020/12/31). age: 20-75 ages

Key exclusion criteria

Participation refusal from principal or agent

Target sample size

230


Research contact person

Name of lead principal investigator

1st name SHOKICHI
Middle name
Last name NAITO

Organization

KITASATO UNIVERSITY HOSPITAL

Division name

DIVISION OF NEPHROLOGY

Zip code

252-0375

Address

1-15-1 Kitasato, Minami, Sagamihara, 252-0374, Japan

TEL

042-778-8111

Email

snaito@med.kitasato-u.ac.jp


Public contact

Name of contact person

1st name SHOKICHI
Middle name
Last name NAITO

Organization

KITASATO UNIVERSITY HOSPITAL

Division name

DIVISION OF NEPHROLOGY

Zip code

252-0375

Address

1-15-1 Kitasato, Minami, Sagamihara, 252-0374, Japan

TEL

042-778-8111

Homepage URL


Email

snaito@med.kitasato-u.ac.jp


Sponsor or person

Institute

KITASATO UNIVERSITY HOSPITAL

Institute

Department

Personal name



Funding Source

Organization

Kitasato University, School Of Medicene

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University Medical Ethics Organization (KMEO)

Address

1-15-1 Kitasato, Minami, Sagamihara, 252-0374, Japan

Tel

042-778-8273

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 04 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

228

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 07 Day

Date of IRB

2018 Year 02 Month 07 Day

Anticipated trial start date

2018 Year 04 Month 10 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Case-control study


Management information

Registered date

2018 Year 04 Month 03 Day

Last modified on

2021 Year 10 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035973


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name